Polar Capital Holdings PLC Protagonist Therapeutics, Inc Transaction History

Polar Capital Holdings PLC

  • $16.4 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$7.06 - $25.52 $2.14 Million - $7.74 Million
-303,429 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$17.63 - $37.1 $1.49 Million - $3.13 Million
84,493 Added 38.59%
303,429 $10.4 Million
Q3 2021

Nov 15, 2021
BUY
$12.95 - $49.69 $1.29 Million - $4.96 Million
99,733 Added 83.67%
218,936 $3.88 Million
Q2 2021

Aug 16, 2021
BUY
$25.57 - $44.88 $3.05 Million - $5.35 Million
119,203 New
119,203 $5.35 Million

Others Institutions Holding PTGX

# of Institutions
195
Shares Held
58.7M
Call Options Held
20.8K
Put Options Held
109K
View Full List

About Protagonist Therapeutics, Inc

PTGX Quotes by TradingView
  • Ticker PTGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,084,100
  • Market Cap $2.19B
  • Description
  • Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...
More about PTGX
Track This Portfolio

Track Polar Capital Holdings PLC Portfolio

Follow Polar Capital Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Polar Capital Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Polar Capital Holdings PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email